Department of Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Via Giacomo Venezian 1, 20133 Milan, Italy.
Cancer Treat Rev. 2014 Jun;40(5):595-604. doi: 10.1016/j.ctrv.2013.11.002. Epub 2013 Nov 14.
microRNAs (herein after miRNAs) represent a recently uncovered class of small and endogenous non-coding RNAs. miRNAs play a well conserved and crucial role in normal biological processes, such as cell differentiation, proliferation and apoptosis through a complicated gene regulation networking. The recent rise of interest in miRNAs in cancer research is ascribed to the breakthrough of their role in many pathological processes, including malignant transformation. miRNAs signatures have been clearly defined for certain types of cancer, with correlation to tumor aggressiveness, therapy response and patient outcome. Furthermore, the use of miRNAs as therapeutic targets for cancer is currently under investigation. The aim of this review is to focus on the role of miRNAs in breast cancer development and to summarize the evidence for their potential diagnostic and therapeutic applications in clinical practice.
microRNAs(miRNAs)是一类新发现的小而内源性的非编码 RNA。miRNAs 通过复杂的基因调控网络,在细胞分化、增殖和凋亡等正常生物学过程中发挥着重要作用。近年来,miRNAs 在癌症研究中的重要性日益凸显,这归因于它们在许多病理过程中的作用,包括恶性转化。已经明确了某些类型癌症的 miRNAs 特征,与肿瘤侵袭性、治疗反应和患者预后相关。此外,miRNAs 作为癌症治疗靶点的应用也正在研究中。本综述的目的是重点关注 miRNAs 在乳腺癌发生发展中的作用,并总结其在临床实践中的潜在诊断和治疗应用的证据。